Analysis of candidate gene co-amplification with MYCN in neuroblastoma

European Journal of Cancer

Volumn 33, Issue 12, 1997, Pages 2037-2042

  George, R E ^d   Kenyon, R ^d   McGuckin, A G ^d   Kohl, N ^a   Kogner, P ^b   Christiansen, H ^c   Pearson, A D J ^d   Lunec, J ^d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY HOSPITAL GIESSEN   (Germany)

^d NONE

Author keywords

Candidate genes; DDX1; DEAD box protein gene; Gene co amplification; MYCN; Neuroblastoma; Ornithine decarboxylase; pG21; Ribonucleotide reductase; Syndecan 1

Indexed keywords

COMPLEMENTARY DNA; DNA; ORNITHINE DECARBOXYLASE; RIBONUCLEOTIDE REDUCTASE; SYNDECAN;

ADOLESCENT; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONFERENCE PAPER; GENE AMPLIFICATION; GENE LOCUS; HUMAN; HUMAN CELL; INFANT; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; GENE AMPLIFICATION; GENES; GENES, MYC; HUMANS; INFANT; NEOPLASM STAGING; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 0031426783     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00206-2     Document Type: Conference Paper

References (35)

1. Amler L. C., Schwab M. Amplified N-myc in human neuroblastoma is often arranged as clustered tandem repeats of differently recombined DNA. Mol Cell Biol. 9:1989;4903-4913.
2. Schneider SS, Hiemstra JL, Zehnbauer BA, et al. Isolation and structural analysis of a 1.2-megabase N-myc amplicon from a human neuroblastoma. Mol Cell Biol 1992, 12, 5563-5570.
3. Hiemstra J. L., Schneider S. S., Brodeur G. M. High-resolution mapping the N-myc amplicon core domain in neuroblastomas. Adv Neuroblastoma Res. 4:1994;51-57.
4. Kohl N. E., Gee C. E., Alt F. W. Activated expression of the N-myc gene in human neuroblastomas and related tumours. Science. 26:1985;1335-1337.
5. Shiloh Y, Korf B, Kohl NE, et al. Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas. Cancer Res 1986, 46, 5297-5301.
6. Young J. L., Miller R. W. Incidence of malignant tumours in U.S. children. J Pediatr. 86:1975;254-258.
7. Brodeur G. M., Seeger R. C., Schwab M., Varmus H. F., Bishop J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 224:1984;1121-1124.
8. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985, 313, 1111-1116.
9. De Bernardi B, Conte M, Mancini A, et al. Localized resectable neuroblastoma: results of the second study of the Italian cooperative group for neuroblastoma. J Clin Oncol 1995, 13, 4, 884-893.
10. Brodeur G. M. Molecular pathology of human neuroblastomas. Semin Diagnost Pathol. 11:(2):1994;118-125.
11. Biedler J. L., Helson L., Spengler B. A. Morphology and growth, tumourigenicity and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33:1973;2643-2652.
12. Tumilowicz J. J., Nichols W. W., Cholon J. J., Greene A. E. Definition of a continuous human cell line derived from neuroblastoma. Cancer Res. 30:1970;2110-2118.
13. Longo L., Christiansen H., Christiansen M. N., Cornaglia-Ferraris P., Lampert F. N-myc amplification at chromosme band 1p32 in neuroblastoma cells as investigated by in situ hybridization. Can Res Clin Oncol. 114:1988;636-640.
14. Carachi R, Raza T, Robertson D, et al. Biological properties of a tumour cell line (NB1-G) derived from human neuroblastoma. Br J Cancer 1987, 55, 407-441.
15. Wheldon T. E., Livingstone A., Wilson L., O'Donoghue J., Gregor A. The radiosensitivity of human neuroblastoma cells estimated from regrowth curves of multicellular tumour spheroids. Br J Radiol. 58:1985;661-664.
16. Biedler J. L., Spengler B. A. Metaphase chromosome anomaly: association with drug resistance and cell-specific products. Science. 191:1976;185-187.
17. Reynolds CP, Biedler JL, Spengler BA, et al. Characterisation of human neoblastoma cell lines established before and after therapy. J Natl Cancer Inst 1986, 76, 375-387.
18. Schlesinger H. R., Gerson J. M., Moorhead P. S., Maguire H., Hummeler K. Establishment and characterisation of human neuroblastoma cell lines. Cancer Res. 36:1976;3094-3100.
19. Shimada H, Chatten J, Newton WA Jr, et al. Histopathologic prognostic factors in neuroblastic tumours: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984, 73, 405-416.
20. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 98:1975;503-517.
21. Feinberg A. P., Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 137:1984;266-267.
22. Schwab M, Alitalo K, Klempnauer K-H, et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 1983, 305, 245-248.
23. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 74:1977;5463-5467.
24. George R. E., Kenyon R. M., McGuckin A. G., et al. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1, and a DEAD box gene, DDX1, with N-myc in neuroblastoma. Oncogene. 12:1996;1583-1587.
25. Amler L. C., Schurman J., Schwab M. The DDX1 gene maps within 400 kbp 5′ to MYCN and is frequently coamplified in human neuroblastoma. Genes Chrom Cancer. 15:1995;134-137.
26. Akiyama K, Kanda N, Yamada M, et al. Megabase-scale analysis of the origin of N-myc amplicons in human neuroblastomas. Nuc Acids Res 1994, 22, 187-193.
27. Noguchi T., Akiyama K., Yokoyama M., Kanda N., Matsunaga T., Nishi Y. Amplification of a DEAD box gene (DDX1) with the MYCN gene in neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus. Genes Chrom Cancer. 15:1996;129-133.
28. Armstrong B. C., Krystal G. W. Isolation and characterisation of complementary DNA for N-cym, a gene encoded by the DNA strand opposite to N-myc. Cell Growth Diff. 33:1992;385-390.
29. Godbout R., Squire J. Amplification of a DEAD box protein gene in retinoblastoma cell lines. Proc Natl Acad Sci USA. 90:1993;7578-7582.
30. Linder P, Lasko PF, Ashburner M, et al. Birth of the DEAD box. Nature 1989, 337, 121-122.
31. Schmid S. R., Linder P. DEAD protein family of putative RNA helicases. Mol Microbiol. 6:1992;283-292.
32. Akao Y, Marukawa O, Morikawa H, et al. The rck/p54 candidate proto-oncogene product is a 54-kilodalton D-E-A-D box protein differentially expressed in human and mouse tissues. Cancer Res 1995, 55, 3444-3449.
33. Squire JA, Thorner PS, Weitzman S, et al. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Oncogene 1995, 10, 1417-1422.
34. Manohar C. F., Salwen H. R., Brodeur G. M., Cohn S. L. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma. Genes Chrom Cancer. 14:1995;196-203.
35. Schwab M., Varmus H. E., Bishop J. M. Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature. 316:1985;160-162.